
Mecotis-G Tablet
Marketer
Atlantis Formulations Pvt Ltd
Salt Composition
Gabapentin (300mg) + Methylcobalamin (500mcg)
Overview Mecotis-G Tablet
Gabapentinoid combination therapy, marketed as Mecotis-G Tablets, effectively manages neuropathic pain. Its mechanism involves modulating nerve cell calcium channel activity to reduce pain sensation. Administered orally, Mecotis-G Tablets may be taken with or without food, ideally before sleep. Consistent daily dosing maintains therapeutic blood levels. Follow your physician's prescribed dosage and duration. Missed doses should be taken upon recollection. Complete the entire treatment course, even with symptom improvement. Abrupt cessation requires prior consultation with your doctor. Commonly reported adverse effects include nausea, peripheral swelling, gait instability, blurred vision, fever, and involuntary eye movements (nystagmus). Dizziness and somnolence may occur; avoid driving or mentally demanding tasks until the medication's effects are known. Report any unusual mood or behavioral changes, new or worsening depression, or suicidal ideation to your doctor immediately. Disclose pregnancy, pregnancy plans, or breastfeeding to your physician before commencing treatment. While generally compatible with other medications, interactions with certain drugs (including antacids and alcohol) may alter efficacy and increase adverse event risk.
Uses of Mecotis-G Tablet
Managing Neuropathic Pain
Major Benefits of Mecotis-G Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Mecotis-G Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Mecotis-G Tablet:
- Dizziness
- Sleepiness
- Tiredness
- Uncoordinated body movements
How to use Mecotis-G Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mecotis-G Tablets can be consumed with or without food, though consistent timing is recommended.
How Mecotis-G Tablet works:
Mecotis-G Tablet combines Gabapentin and Methylcobalamin to alleviate neuropathic pain. Gabapentin, an alpha-2-delta ligand, reduces pain signals by influencing nerve cell calcium channels. Methylcobalamin, a B vitamin, supports myelin production, protecting nerve fibers and aiding the repair of damaged nerve cells. This dual action provides effective neuropathic pain relief.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Mecotis-G tablets and alcohol may lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Employing Mecotis-G Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is recommended.
Breast feedingSAFE IF PRESCRIBED
Using Mecotis-G tablets while breastfeeding appears to pose minimal risk. Available data from human studies indicate insignificant danger to the infant. However, infant monitoring for drowsiness and increased weight is recommended.
DrivingUNSAFE
Taking Mecotis-G Tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Mecotis-G Tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Mecotis-G Tablet's efficacy and safety in individuals with hepatic impairment. Seek medical advice before use.
What if you forget to take Mecotis-G Tablet :
Should you forget a Mecotis-G Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mecotis-G Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
